{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T21:30:48Z","timestamp":1794000648752,"version":"4.8.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"32","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"funder":[{"name":"Netherlands Heart Foundation","award":["2008B035"],"award-info":[{"award-number":["2008B035"]}]},{"name":"Netherlands Heart Institute; Unrestricted","id":[{"id":"https:\/\/ror.org\/01mh6b283","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005035","name":"Biotronik","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005035","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Boehringer-Ingelheim"},{"DOI":"10.13039\/100008497","name":"Boston Scientific","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi-Aventis","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006279","name":"St Jude Medical","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006279","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100014470","name":"Netherlands Heart Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014470","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8,21]]},"DOI":"10.1093\/eurheartj\/ehx739","type":"journal-article","created":{"date-parts":[[2017,12,5]],"date-time":"2017-12-05T15:16:37Z","timestamp":1512486997000},"page":"2987-2996","source":"Crossref","is-referenced-by-count":279,"title":["Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial"],"prefix":"10.1093","volume":"39","author":[{"given":"Michiel","family":"Rienstra","sequence":"first","affiliation":[{"name":"Department of Cardiology, University of Groningen University Medical Centre Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne H","family":"Hobbelt","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Groningen University Medical Centre Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Alings","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Amphia Hospital, Breda, The Netherlands"},{"name":"Julius Clinical, Zeist, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan G P","family":"Tijssen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Academic Medical Centre - University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelle D","family":"Smit","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Groningen University Medical Centre Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Br\u00fcgemann","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Groningen University Medical Centre Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastiaan","family":"Geelhoed","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Groningen University Medical Centre Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G","family":"Tieleman","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Martini Hospital, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans L","family":"Hillege","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Groningen University Medical Centre Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Tukkie","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Spaarne Hospital, Haarlem, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk J","family":"Van Veldhuisen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Groningen University Medical Centre Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry J G M","family":"Crijns","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Maastricht University Medical Centre+, The Netherlands"},{"name":"Cardiovascular Research Institute Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle C","family":"Van Gelder","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Groningen University Medical Centre Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the RACE 3 Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,2,1]]},"reference":[{"key":"key\n\t\t\t\t20180827092421_ehx739-B1","first-page":"1591","article-title":"The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and meta-analysis","volume":"37","author":"Ganesan","year":"2016","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180827092421_ehx739-B2","first-page":"1339","article-title":"Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT","volume":"38","author":"Van Gelder","year":"2017","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180827092421_ehx739-B3","first-page":"1509","article-title":"Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study","volume":"109","author":"Corley","year":"2004","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180827092421_ehx739-B4","first-page":"2335","article-title":"Atrial remodeling and atrial fibrillation: recent advances and translational perspectives","volume":"63","author":"Nattel","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180827092421_ehx739-B5","first-page":"21","article-title":"Delayed rhythm control of atrial fibrillation may be a cause of failure to prevent recurrences: reasons for change to active antiarrhythmic treatment at the time of the first detected episode","volume":"10","author":"Cosio","year":"2007","journal-title":"Europace"},{"key":"key\n\t\t\t\t20180827092421_ehx739-B6","first-page":"2893","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180827092421_ehx739-B7","first-page":"1268","article-title":"Targeting inflammation and oxidative stress in atrial fibrillation: role of 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibition with statins","volume":"20","author":"Pinho-Gomes","year":"2014","journal-title":"Antioxid Redox Signal"},{"key":"key\n\t\t\t\t20180827092421_ehx739-B8","first-page":"1448","article-title":"Early management of atrial fibrillation to prevent cardiovascular complications","volume":"35","author":"Nattel","year":"2014","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180827092421_ehx739-B9","first-page":"2032","article-title":"Blood-pressure and cholesterol lowering in persons without cardiovascular disease","volume":"374","author":"Yusuf","year":"2016","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180827092421_ehx739-B10","first-page":"610","article-title":"Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention","volume":"13","author":"Savelieva","year":"2011","journal-title":"Europace"},{"key":"key\n\t\t\t\t20180827092421_ehx739-B11","first-page":"155","article-title":"Aldosterone pathway blockade to prevent atrial fibrillation: a systematic review and meta-analysis","volume":"231","author":"Neefs","year":"2017","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t20180827092421_ehx739-B12","first-page":"1598","article-title":"Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) study","volume":"59","author":"Swedberg","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180827092421_ehx739-B13","first-page":"1573","article-title":"Novel mechanisms in the pathogenesis of atrial fibrillation: practical applications","volume":"37","author":"Lau","year":"2016","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180827092421_ehx739-B14","first-page":"2222","article-title":"Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study","volume":"64","author":"Pathak","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180827092421_ehx739-B15","first-page":"1787","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180827092421_ehx739-B16","first-page":"2315","article-title":"2016 European Guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180827092421_ehx739-B17","first-page":"712","article-title":"Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study","volume":"45","author":"Wachtell","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180827092421_ehx739-B18","first-page":"1205","article-title":"Antihypertensive treatment and risk of atrial fibrillation: a nationwide study","volume":"35","author":"Marott","year":"2014","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180827092421_ehx739-B19","first-page":"354","article-title":"Routine versus aggressive upstream rhythm control for prevention of early atrial fibrillation in heart failure: background, aims and design of the RACE 3 study","volume":"21","author":"Alings","year":"2013","journal-title":"Neth Heart J"},{"key":"key\n\t\t\t\t20180827092421_ehx739-B20","first-page":"213","article-title":"Comparative analysis of two rates","volume":"4","author":"Miettinen","year":"1985","journal-title":"Stat Med"},{"key":"key\n\t\t\t\t20180827092421_ehx739-B21","first-page":"d2304.","article-title":"How to obtain the P value from a confidence interval","volume":"343","author":"Altman","year":"2011","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20180827092421_ehx739-B22","first-page":"928","article-title":"Irbesartan in patients with atrial fibrillation","volume":"364","author":"ACTIVE-I Investigators","year":"2011","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180827092421_ehx739-B23","first-page":"705","article-title":"Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study","volume":"45","author":"Wachtell","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180827092421_ehx739-B24","first-page":"1131","article-title":"Renal denervation for improving outcomes of catheter ablation in patients with atrial fibrillation and hypertension: early experience","volume":"11","author":"Pokushalov","year":"2014","journal-title":"Heart Rhythm"},{"key":"key\n\t\t\t\t20180827092421_ehx739-B25","first-page":"1788","article-title":"Effect of aggressive blood pressure control on the recurrence of atrial fibrillation after catheter ablation: a randomized, open-label clinical trial (SMAC-AF [Substrate Modification With Aggressive Blood Pressure Control])","volume":"135","author":"Parkash","year":"2017","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180827092421_ehx739-B26","first-page":"1744","article-title":"Perioperative rosuvastatin in cardiac surgery","volume":"374","author":"Zheng","year":"2016","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180827092421_ehx739-B27","first-page":"11","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180827092421_ehx739-B28","first-page":"2217","article-title":"Heart failure with preserved ejection fraction and atrial fibrillation: vicious twins","volume":"68","author":"Kotecha","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180827092421_ehx739-B29","first-page":"1715","article-title":"Lone atrial fibrillation: does it exist?","volume":"63","author":"Wyse","year":"2014","journal-title":"J Am Coll Cardiol"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartj\/article-pdf\/39\/32\/2987\/25564305\/ehx739.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T13:05:52Z","timestamp":1589807152000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/39\/32\/2987\/4786620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,1]]},"references-count":29,"journal-issue":{"issue":"32","published-online":{"date-parts":[[2018,2,1]]},"published-print":{"date-parts":[[2018,8,21]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehx739","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,8,21]]},"published":{"date-parts":[[2018,2,1]]}}}